KUMULUS VAPE (ALVAP.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:ALVAP • FR0013419876

3.96 EUR
+0.02 (+0.51%)
Last: Feb 3, 2026, 07:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ALVAP. ALVAP was compared to 59 industry peers in the Specialty Retail industry. ALVAP has an excellent financial health rating, but there are some minor concerns on its profitability. ALVAP is valued correctly, but it does not seem to be growing. Finally ALVAP also has an excellent dividend rating. These ratings would make ALVAP suitable for dividend investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year ALVAP was profitable.
  • In the past year ALVAP has reported a negative cash flow from operations.
  • Each year in the past 5 years ALVAP has been profitable.
  • ALVAP had negative operating cash flow in 4 of the past 5 years.
ALVAP.PA Yearly Net Income VS EBIT VS OCF VS FCFALVAP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

1.2 Ratios

  • ALVAP has a Return On Assets of 9.80%. This is amongst the best in the industry. ALVAP outperforms 86.44% of its industry peers.
  • ALVAP has a better Return On Equity (16.02%) than 72.88% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 12.74%, ALVAP belongs to the top of the industry, outperforming 83.05% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for ALVAP is above the industry average of 10.14%.
Industry RankSector Rank
ROA 9.8%
ROE 16.02%
ROIC 12.74%
ROA(3y)9.89%
ROA(5y)10.27%
ROE(3y)16.02%
ROE(5y)15.99%
ROIC(3y)13.64%
ROIC(5y)14.38%
ALVAP.PA Yearly ROA, ROE, ROICALVAP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • ALVAP has a better Profit Margin (4.35%) than 76.27% of its industry peers.
  • ALVAP's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 5.89%, ALVAP is in the better half of the industry, outperforming 71.19% of the companies in the same industry.
  • ALVAP's Operating Margin has improved in the last couple of years.
  • ALVAP has a Gross Margin of 23.53%. This is in the lower half of the industry: ALVAP underperforms 66.10% of its industry peers.
  • ALVAP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.89%
PM (TTM) 4.35%
GM 23.53%
OM growth 3Y0.64%
OM growth 5Y19.19%
PM growth 3Y4.02%
PM growth 5Y42.75%
GM growth 3Y5.68%
GM growth 5Y0.12%
ALVAP.PA Yearly Profit, Operating, Gross MarginsALVAP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 5 10 15 20

More info and screens

7

2. Health

2.1 Basic Checks

  • ALVAP has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • Compared to 1 year ago, ALVAP has about the same amount of shares outstanding.
  • The number of shares outstanding for ALVAP has been increased compared to 5 years ago.
  • Compared to 1 year ago, ALVAP has an improved debt to assets ratio.
ALVAP.PA Yearly Shares OutstandingALVAP.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALVAP.PA Yearly Total Debt VS Total AssetsALVAP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

  • An Altman-Z score of 4.53 indicates that ALVAP is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 4.53, ALVAP belongs to the best of the industry, outperforming 88.14% of the companies in the same industry.
  • ALVAP has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
  • With an excellent Debt to Equity ratio value of 0.21, ALVAP belongs to the best of the industry, outperforming 83.05% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z 4.53
ROIC/WACC1.83
WACC6.95%
ALVAP.PA Yearly LT Debt VS Equity VS FCFALVAP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

  • A Current Ratio of 3.30 indicates that ALVAP has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 3.30, ALVAP belongs to the best of the industry, outperforming 93.22% of the companies in the same industry.
  • A Quick Ratio of 1.76 indicates that ALVAP should not have too much problems paying its short term obligations.
  • ALVAP's Quick ratio of 1.76 is amongst the best of the industry. ALVAP outperforms 93.22% of its industry peers.
Industry RankSector Rank
Current Ratio 3.3
Quick Ratio 1.76
ALVAP.PA Yearly Current Assets VS Current LiabilitesALVAP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

3

3. Growth

3.1 Past

  • ALVAP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21.52%.
  • Measured over the past years, ALVAP shows a very strong growth in Earnings Per Share. The EPS has been growing by 97.48% on average per year.
  • Looking at the last year, ALVAP shows a very negative growth in Revenue. The Revenue has decreased by -34.12% in the last year.
  • ALVAP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 41.89% yearly.
EPS 1Y (TTM)-21.52%
EPS 3Y20.5%
EPS 5Y97.48%
EPS Q2Q%-23.21%
Revenue 1Y (TTM)-34.12%
Revenue growth 3Y20.74%
Revenue growth 5Y41.89%
Sales Q2Q%-51.16%

3.2 Future

  • Based on estimates for the next years, ALVAP will show a decrease in Earnings Per Share. The EPS will decrease by -1.02% on average per year.
  • The Revenue is expected to decrease by -0.11% on average over the next years.
EPS Next Y-34.55%
EPS Next 2Y-4.02%
EPS Next 3Y-1.02%
EPS Next 5YN/A
Revenue Next Year-6.25%
Revenue Next 2Y-0.99%
Revenue Next 3Y-0.11%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALVAP.PA Yearly Revenue VS EstimatesALVAP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ALVAP.PA Yearly EPS VS EstimatesALVAP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 4.89, the valuation of ALVAP can be described as very cheap.
  • ALVAP's Price/Earnings ratio is rather cheap when compared to the industry. ALVAP is cheaper than 98.31% of the companies in the same industry.
  • ALVAP's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.18.
  • With a Price/Forward Earnings ratio of 7.12, the valuation of ALVAP can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, ALVAP is valued cheaper than 88.14% of the companies in the same industry.
  • ALVAP is valuated cheaply when we compare the Price/Forward Earnings ratio to 25.51, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 4.89
Fwd PE 7.12
ALVAP.PA Price Earnings VS Forward Price EarningsALVAP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ALVAP is valued cheaply inside the industry as 94.92% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.55
ALVAP.PA Per share dataALVAP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The decent profitability rating of ALVAP may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.05
EPS Next 2Y-4.02%
EPS Next 3Y-1.02%

More info and screens

7

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 4.30%, ALVAP is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 1.35, ALVAP pays a better dividend. On top of this ALVAP pays more dividend than 91.53% of the companies listed in the same industry.
  • ALVAP's Dividend Yield is rather good when compared to the S&P500 average which is at 1.83.
Industry RankSector Rank
Dividend Yield 4.3%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years2
ALVAP.PA Yearly Dividends per shareALVAP.PA Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

  • 17.40% of the earnings are spent on dividend by ALVAP. This is a low number and sustainable payout ratio.
DP17.4%
EPS Next 2Y-4.02%
EPS Next 3Y-1.02%
ALVAP.PA Yearly Income VS Free CF VS DividendALVAP.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 2M -2M 4M
ALVAP.PA Dividend Payout.ALVAP.PA Dividend Payout, showing the Payout Ratio.ALVAP.PA Dividend Payout.PayoutRetained Earnings

More info and screens

KUMULUS VAPE

EPA:ALVAP (2/3/2026, 7:00:00 PM)

3.96

+0.02 (+0.51%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners36.98%
Ins Owner ChangeN/A
Market Cap12.16M
Revenue(TTM)60.68M
Net Income(TTM)2.64M
Analysts86.67
Price Target7.04 (77.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.3%
Yearly Dividend0.15
Dividend Growth(5Y)N/A
DP17.4%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-4.17%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)25.58%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 4.89
Fwd PE 7.12
P/S 0.2
P/FCF N/A
P/OCF N/A
P/B 0.74
P/tB 0.91
EV/EBITDA 2.55
EPS(TTM)0.81
EY20.45%
EPS(NY)0.56
Fwd EY14.05%
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)-0.36
OCFYN/A
SpS19.77
BVpS5.37
TBVpS4.36
PEG (NY)N/A
PEG (5Y)0.05
Graham Number9.89
Profitability
Industry RankSector Rank
ROA 9.8%
ROE 16.02%
ROCE 17.82%
ROIC 12.74%
ROICexc 17.68%
ROICexgc 22.48%
OM 5.89%
PM (TTM) 4.35%
GM 23.53%
FCFM N/A
ROA(3y)9.89%
ROA(5y)10.27%
ROE(3y)16.02%
ROE(5y)15.99%
ROIC(3y)13.64%
ROIC(5y)14.38%
ROICexc(3y)17.75%
ROICexc(5y)21.73%
ROICexgc(3y)22.02%
ROICexgc(5y)24.77%
ROCE(3y)19.12%
ROCE(5y)20.26%
ROICexgc growth 3Y1.55%
ROICexgc growth 5Y9.12%
ROICexc growth 3Y-5.62%
ROICexc growth 5Y6.22%
OM growth 3Y0.64%
OM growth 5Y19.19%
PM growth 3Y4.02%
PM growth 5Y42.75%
GM growth 3Y5.68%
GM growth 5Y0.12%
F-Score3
Asset Turnover2.25
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA 0.82
Cap/Depr 57.64%
Cap/Sales 0.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.3
Quick Ratio 1.76
Altman-Z 4.53
F-Score3
WACC6.95%
ROIC/WACC1.83
Cap/Depr(3y)181.05%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.97%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.52%
EPS 3Y20.5%
EPS 5Y97.48%
EPS Q2Q%-23.21%
EPS Next Y-34.55%
EPS Next 2Y-4.02%
EPS Next 3Y-1.02%
EPS Next 5YN/A
Revenue 1Y (TTM)-34.12%
Revenue growth 3Y20.74%
Revenue growth 5Y41.89%
Sales Q2Q%-51.16%
Revenue Next Year-6.25%
Revenue Next 2Y-0.99%
Revenue Next 3Y-0.11%
Revenue Next 5YN/A
EBIT growth 1Y-24.22%
EBIT growth 3Y21.51%
EBIT growth 5Y69.12%
EBIT Next Year-5.88%
EBIT Next 3Y3.78%
EBIT Next 5YN/A
FCF growth 1Y-124.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-117.39%
OCF growth 3YN/A
OCF growth 5YN/A

KUMULUS VAPE / ALVAP.PA FAQ

What is the fundamental rating for ALVAP stock?

ChartMill assigns a fundamental rating of 6 / 10 to ALVAP.PA.


What is the valuation status of KUMULUS VAPE (ALVAP.PA) stock?

ChartMill assigns a valuation rating of 6 / 10 to KUMULUS VAPE (ALVAP.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for KUMULUS VAPE?

KUMULUS VAPE (ALVAP.PA) has a profitability rating of 6 / 10.


What are the PE and PB ratios of KUMULUS VAPE (ALVAP.PA) stock?

The Price/Earnings (PE) ratio for KUMULUS VAPE (ALVAP.PA) is 4.89 and the Price/Book (PB) ratio is 0.74.


Can you provide the financial health for ALVAP stock?

The financial health rating of KUMULUS VAPE (ALVAP.PA) is 7 / 10.